• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药代动力学和药效学:重症监护病房中的最佳抗菌治疗。

Pharmacokinetics and pharmacodynamics: optimal antimicrobial therapy in the intensive care unit.

机构信息

Albany College of Pharmacy and Health Sciences, Albany, NY, USA.

出版信息

Crit Care Clin. 2011 Jan;27(1):1-18. doi: 10.1016/j.ccc.2010.11.003.

DOI:10.1016/j.ccc.2010.11.003
PMID:21144983
Abstract

This article reviews the principles of antimicrobial pharmacokinetics and pharmacodynamics in the context of the ICU for the most commonly used antibiotics. For therapy to truly be efficacious, the regimen must be effective against the organism, but not harmful to the patient. We review how optimization of chemotherapy requires a careful balancing of efficacy against toxicity when selecting dose and dose schedules. In addition, we discuss the importance of considering concentrations at the site of infection and how dose optimization can help suppress resistance emergence and preserve our antimicrobial armamentarium for the future. Finally, we examine combination chemotherapy and strategies for optimizing the administration of multiple agents.

摘要

本文回顾了 ICU 中最常用抗生素的抗菌药代动力学和药效学原则。为了使治疗真正有效,方案必须对病原体有效,但对患者无害。我们回顾了在选择剂量和剂量方案时,如何通过平衡疗效和毒性来优化化疗。此外,我们还讨论了考虑感染部位浓度以及如何通过优化剂量来帮助抑制耐药性出现并为未来保留我们的抗菌药物的重要性。最后,我们研究了联合化疗和优化多种药物给药的策略。

相似文献

1
Pharmacokinetics and pharmacodynamics: optimal antimicrobial therapy in the intensive care unit.药代动力学和药效学:重症监护病房中的最佳抗菌治疗。
Crit Care Clin. 2011 Jan;27(1):1-18. doi: 10.1016/j.ccc.2010.11.003.
2
Bench-to-bedside review: antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit.从实验台到病床的综述:旨在预防重症监护病房细菌耐药性产生的抗菌药物使用策略
Crit Care. 2005 Oct 5;9(5):459-64. doi: 10.1186/cc3757. Epub 2005 Jun 27.
3
Antibacterial dosage in intensive-care-unit patients based on pharmacokinetic/pharmacodynamic principles.基于药代动力学/药效学原理的重症监护病房患者抗菌药物剂量
Curr Opin Crit Care. 2006 Oct;12(5):477-82. doi: 10.1097/01.ccx.0000244130.77365.c2.
4
Pharmacokinetics and pharmacodynamics of antimicrobial drugs in intensive care unit patients.重症监护病房患者抗菌药物的药代动力学和药效学。
Shock. 2013 May;39 Suppl 1:24-8. doi: 10.1097/SHK.0b013e31828faec0.
5
Antibiotic stewardship in the intensive care unit.重症监护病房的抗生素管理。
Semin Respir Crit Care Med. 2011 Apr;32(2):215-27. doi: 10.1055/s-0031-1275534. Epub 2011 Apr 19.
6
[Drug interactions of antimicrobial agents in children with cancer].[癌症患儿抗菌药物的药物相互作用]
Klin Padiatr. 2005 Nov;217 Suppl 1:S165-74. doi: 10.1055/s-2005-872510.
7
Review of pharmacokinetics and pharmacodynamics of antimicrobial agents.抗菌药物的药代动力学与药效学综述
Mayo Clin Proc. 1998 Nov;73(11):1114-22. doi: 10.4065/73.11.1114.
8
Some current issues in the pharmacokinetics/pharmacodynamics of antimicrobials in intensive care.一些当前重症监护抗菌药物药代动力学/药效学的问题。
Minerva Anestesiol. 2010 Jul;76(7):509-24.
9
In vitro activity and pharmacodynamics of commonly used antibiotics against adult systemic isolates of Escherichia coli and Pseudomonas aeruginosa at Forty US Hospitals.四十家美国医院成人系统分离大肠埃希菌和铜绿假单胞菌常用抗生素的体外活性和药效动力学研究。
Clin Ther. 2009 Nov;31(11):2678-88. doi: 10.1016/j.clinthera.2009.11.021.
10
How to optimise antimicrobial prescriptions in the Intensive Care Unit: principles of individualised dosing using pharmacokinetics and pharmacodynamics.如何优化重症监护病房的抗菌药物处方:基于药代动力学和药效学的个体化给药原则。
Int J Antimicrob Agents. 2012 Mar;39(3):187-92. doi: 10.1016/j.ijantimicag.2011.11.002. Epub 2012 Jan 9.

引用本文的文献

1
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses.危重症患者抗生素的同位素稀释高效液相色谱-串联质谱多重治疗药物监测
J Vis Exp. 2018 Aug 30(138):58148. doi: 10.3791/58148.
2
Collaborative Pharmacokinetic-Pharmacodynamic Research for Optimization of Antimicrobial Therapy.用于优化抗菌治疗的药代动力学-药效学协作研究
Infect Chemother. 2016 Sep;48(3):254-256. doi: 10.3947/ic.2016.48.3.254.
3
Experimental Simulation of the Effects of an Initial Antibiotic Treatment on a Subsequent Treatment after Initial Therapy Failure.
初始治疗失败后再次治疗时初始抗生素治疗效果的实验模拟。
Antibiotics (Basel). 2014 Feb 17;3(1):49-63. doi: 10.3390/antibiotics3010049.
4
Antibiotic stewardship in the intensive care unit.重症监护病房的抗生素管理
Crit Care. 2014 Aug 13;18(5):480. doi: 10.1186/s13054-014-0480-6.
5
Optimal dosing of antibiotics in critically ill patients by using continuous/extended infusions: a systematic review and meta-analysis.通过持续/延长输注对危重症患者进行抗生素的优化给药:一项系统评价和荟萃分析
Crit Care. 2013 Nov 29;17(6):R279. doi: 10.1186/cc13134.
6
Clinical pharmacodynamic index identification for micafungin in esophageal candidiasis: dosing strategy optimization.米卡芬净治疗食管念珠菌病的临床药效动力学指标鉴定:给药策略优化。
Antimicrob Agents Chemother. 2013 Nov;57(11):5714-6. doi: 10.1128/AAC.01057-13. Epub 2013 Aug 19.
7
Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.成人社区获得性肺炎和医院获得性肺炎的诊断与管理指南:ICS/NCCP(I)联合推荐意见
Lung India. 2012 Jul;29(Suppl 2):S27-62. doi: 10.4103/0970-2113.99248.
8
Year in review 2010: Critical Care--Infection.2010 年年鉴:重症监护 - 感染。
Crit Care. 2011;15(6):238. doi: 10.1186/cc10425. Epub 2011 Dec 5.
9
Ertapenem pharmacokinetics and pharmacodynamics during continuous ambulatory peritoneal dialysis.厄他培南在持续非卧床腹膜透析期间的药代动力学和药效学。
Antimicrob Agents Chemother. 2012 Feb;56(2):725-30. doi: 10.1128/AAC.05515-11. Epub 2011 Nov 14.
10
Determination of meropenem penetration into the lung from Sparse data.基于稀疏数据测定美罗培南在肺部的渗透率。
Antimicrob Agents Chemother. 2011 Dec;55(12):5959-61. doi: 10.1128/AAC.05066-11.